Research from Vaxart Inc. Has Provided New Study Findings on Human Papillomavirus 16 (Elimination of Human Papillomavirus 16-Positive Tumors by a Mucosal rAd5 Therapeutic Vaccination in a Pre-Clinical Murine Study)

Press/Media

Period15 Oct 2024

Media coverage

1

Media coverage

  • TitleResearch from Vaxart Inc. Has Provided New Study Findings on Human Papillomavirus 16 (Elimination of Human Papillomavirus 16-Positive Tumors by a Mucosal rAd5 Therapeutic Vaccination in a Pre-Clinical Murine Study)
    Media name/outletVaccine Daily
    Country/TerritoryUnited States
    Date15/10/24
    PersonsAnne Moore